On Demand - Cardiac PET - Low-Cost Daily Rubidium is Here-Presentation Slides

Presentation Slides

Pdf Summary

The document discusses the clinical advantages of Cardiac Positron Emission Tomography (PET) using Rubidium-82 (Rb-82). It features presentations by Dr. Vasken Dilsizian, Don Elting, and Brendon Loiselle. <br /><br />Dr. Dilsizian highlights the implementation of Appropriate Use Criteria (AUC) for PET myocardial perfusion imaging (MPI) to optimize patient care and cost-effectiveness in the healthcare system. The AUC process involves evaluating clinical scenarios based on systematic review, outcome data, clinical expertise, and clinical practice. The scenarios are scored as appropriate, may be appropriate, or rarely appropriate.<br /><br />He then discusses the clinical applications of Cardiac PET using Rb-82 in various scenarios, such as symptomatic patients with suspected or known coronary artery disease (CAD), asymptomatic patients, heart failure, cardiac sarcoidosis, arrhythmias, syncope, coronary microvascular dysfunction, specific populations, prior testing or procedures, and preoperative evaluation for non-cardiac surgery.<br /><br />The document also emphasizes the shift from anatomical gold standards to functional assessments in the management of CAD. Cardiac PET allows for the quantification of myocardial blood flow (MBF) in absolute terms, providing a comprehensive evaluation of atherosclerosis, microvascular dysfunction, and balanced reduction of MBF in all three major coronary arteries.<br /><br />Don Elting discusses the implementation of a daily Rubidium generator for Cardiac PET. The process involves considerations such as the familiarity of radiologist/cardiologists with Rubidium, interpreting images, marketing to referring physicians, scanner capabilities, necessary ancillary equipment, insurance coverage, staffing, and delivery of the infusion system.<br /><br />Brendon Loiselle presents Cardiac PET as a solution for improved diagnostic accuracy, lower radiation exposure, shorter image acquisition times, and the quantification of MBF, which offers strong prognostic power. He mentions the continued growth in the use of Cardiac PET, highlighting its benefits and Society support for its implementation.<br /><br />The document concludes by presenting CDL Nuclear Technologies' on-demand mobile Rubidium system, which offers an affordable and accessible solution for Cardiac PET. The system can be reserved for a day of service, with the delivery and removal of the Rubidium infusion system before and after clinic hours. The cost model for Cardiac PET/CT with Rubidium is also provided.

Keywords

Cardiac Positron Emission Tomography

Rubidium-82

clinical advantages

Appropriate Use Criteria

myocardial perfusion imaging

healthcare system

coronary artery disease

microvascular dysfunction

myocardial blood flow

diagnostic accuracy